fernando@wizards.us

National Institutes of Health (April, 2025) A study of osteoarthritis patients treated with PRP injections observed favorable outcomes lasting for at least 1-year. Further, repeated PRP injections and high levels of sports activity emerged as positive prognostic factors. The latter led researchers to also recommend systematically offering PRP therapy to competitive athletes presenting with symptomatic […]

National Institutes of Health (September, 2024) Research consolidating key clinical trials, methodologies, efficacy outcomes, and safety considerations discovered that PRP therapy continues to deliver promising results for treating rotator cuff injuries, offering potential benefits in accelerating healing, reducing pain, and improving functional outcomes. The evidence from clinical trials suggests that PRP therapy may be an

National Institutes of Health (January, 2024) A study was conducted on athletes of an average age of 32.7 years, who had sustained ACL injuries and received PRP therapy.The average treatment was 2.8 PRP sessions (injections). MRI evaluations confirmed that ligament continuity was regained in all cases. All the patients returned to their pre-injury level in